[Combination for initial therapy in hypertension, is it useful?]

Area of Science:

• Cardiology
• Nephrology
• Public Health

Background:

• Hypertension is the leading cause of global mortality, contributing to cardiovascular and renal diseases.
• Despite known benefits, blood pressure control remains inadequate, even in high-income nations.
• Approximately 50% of hypertensive patients have uncontrolled blood pressure, with 75% not achieving control with monotherapy.

Purpose of the Study:

• To review the benefits of initiating antihypertensive treatment with combined drug therapy.
• To highlight strategies for improving blood pressure control in hypertensive patients.

Main Methods:

• Literature review focusing on studies evaluating antihypertensive treatment strategies.
• Analysis of data on monotherapy versus combination therapy efficacy.
• Examination of guidelines and evidence for early combination treatment.

Main Results:

• Monotherapy is often insufficient for adequate blood pressure control.
• Early initiation of 2-drug combination therapy is more effective than monotherapy.
• Fixed-dose combinations in a single pill improve adherence and control.

Conclusions:

• Initiating hypertension treatment with a 2-drug combination is a superior strategy for achieving blood pressure control.
• Addressing treatment inertia and optimizing therapeutic regimens are crucial for managing hypertension effectively.